Using data from more than 20,000 patients with neurological diseases, researchers have established an...
Up To Date
Latest News
UK-Austrian fungal infection specialist F2G Ltd has secured a €50.8m (US $60.8m) financing from new and...
Evotec SE and its new partner Resolute Therapeutics, a specialist in antimicrobial resistance (AMR), have...
BioNTech SE and its partner Fosun Pharma Co. Ltd have selected another COVID-19 vaccine candidate for Phase I...
Evotec SE has secured a strategic partnership with Secarna Pharmaceuticals GmbH to co-develop a LNA drug...
The European Commission has reserved 300 million doses from Sanofi SA’/GSK plc’s adjuvanted recombinant...
Share
